These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9446035)

  • 1. Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.
    Bauditz J; Lochs H; Schreiber S
    N Engl J Med; 1998 Jan; 338(5):334. PubMed ID: 9446035
    [No Abstract]   [Full Text] [Related]  

  • 2. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
    Targan SR; Hanauer SB; van Deventer SJ; Mayer L; Present DH; Braakman T; DeWoody KL; Schaible TF; Rutgeerts PJ
    N Engl J Med; 1997 Oct; 337(15):1029-35. PubMed ID: 9321530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Crohn's disease at the turn of the century.
    Bickston SJ; Cominelli F
    N Engl J Med; 1998 Aug; 339(6):401-2. PubMed ID: 9691110
    [No Abstract]   [Full Text] [Related]  

  • 4. Chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.
    Hawkey CJ; Stack WA
    N Engl J Med; 1998 Jan; 338(5):333-4. PubMed ID: 9446034
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy of inflammatory bowel diseases].
    Silvennoinen J; Niemelä S
    Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
    [No Abstract]   [Full Text] [Related]  

  • 6. Crohn's disease, TNF-alpha, and the leaky gut. The chicken or the egg?
    Hollander D
    Am J Gastroenterol; 2002 Aug; 97(8):1867-8. PubMed ID: 12190145
    [No Abstract]   [Full Text] [Related]  

  • 7. Algorithm for the treatment of Crohn's disease: incorporation of emerging therapies.
    Souney PF
    Am J Gastroenterol; 2000 Sep; 95(9):2381-3. PubMed ID: 11007248
    [No Abstract]   [Full Text] [Related]  

  • 8. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
    González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
    J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
    [No Abstract]   [Full Text] [Related]  

  • 9. A chimeric anti-TNFalpha monoclonal antibody (cA2) in vivo removes TNFalpha-producing cells in Crohn's disease.
    Urra JM; Arteta M; Gómez-Caturla A; García-Durán F
    Hum Antibodies; 2001; 10(2):91-4. PubMed ID: 11673664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ulcerative colitis and Crohn's disease].
    Matsuoka K; Hibi T
    Nihon Rinsho; 2005 May; 63 Suppl 5():507-11. PubMed ID: 15954400
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of Crohn's disease with anti-TNF alpha].
    Lémann M
    Rev Prat; 1998 May; 48(10):1049-50. PubMed ID: 9781146
    [No Abstract]   [Full Text] [Related]  

  • 12. [Present states of development in new drugs and treatment of inflammatory bowel disease].
    Asakura H; Sugimura K
    Nihon Rinsho; 1999 Nov; 57(11):2490-5. PubMed ID: 10572418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).
    van Dullemen HM; van Deventer SJ; Hommes DW; Bijl HA; Jansen J; Tytgat GN; Woody J
    Gastroenterology; 1995 Jul; 109(1):129-35. PubMed ID: 7797011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New drug treatments for rheumatoid arthritis].
    Nordström DC; Konttinen YT
    Duodecim; 2000; 116(11):1221-5. PubMed ID: 11989008
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of patients with Crohn's disease and concomitant chronic hepatitis C with a chimeric monoclonal antibody to TNF.
    Holtmann MH; Galle PR; Neurath MF
    Am J Gastroenterol; 2003 Feb; 98(2):504-5. PubMed ID: 12591081
    [No Abstract]   [Full Text] [Related]  

  • 16. TNF-alpha-targeted therapy in rheumatoid arthritis.
    Wendling D; Toussirot E
    Rev Rhum Engl Ed; 1999 Apr; 66(4):187-91. PubMed ID: 10339773
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of Crohn's disease in a patient taking etanercept.
    Oh J; Arkfeld DG; Horwitz DA
    J Rheumatol; 2005 Apr; 32(4):752-3. PubMed ID: 15801037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease.
    Brown SJ; Abreu MT
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):160-8. PubMed ID: 15782540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effectiveness of short-term administration of monoclonal antibody cA2 against tumor necrosis factor alpha in Crohn disease].
    Schreiber S; Koop I
    Z Gastroenterol; 1998 Apr; 36(4):349-51. PubMed ID: 9612932
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug therapy and nutrition therapy of a young patient with Crohn disease].
    Verkasalo M
    Duodecim; 2003; 119(7):617-24. PubMed ID: 12762201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.